【SUNZEN 0148 交流专区】宏诚生科

icy97

宏誠5配3附加股‧1附加股送1憑單

2015-08-27 10:27      
（吉隆坡26日訊）宏誠生物科技（SUNZEN，0148，創業板消費品組）擬展開5配3比例發售附加股，再以1附加股送1憑單，以及成立發股計劃（SIS），最高籌措2千769萬5千令吉用作營運開銷。

轉換價為25仙
該公司發文告表示，建議以5配3比例發售最高1億9千257萬9千515股新股，再以1附加股送1憑單，附加股發售價和憑單轉換價均為25仙。

宏誠生物科技料通過上述活動，籌措最多2千769萬5千令吉，其中1千400萬令吉將用來採購原料、850萬令吉採購庫存、94萬令吉為員工薪酬、322萬令吉為行銷開銷，其餘103萬5千令吉作為其他管理和營運開銷。

與此同時，該公司也計劃成立佔繳足資本逾30%的發股計劃，保留給特定董事與僱員認購，期限為5年。（星洲日報／財經）

Type	Announcement
Subject	MULTIPLE PROPOSALS
Description	SUNZEN BIOTECH BERHAD ("SUNZEN" OR THE "COMPANY")(I)        PROPOSED RIGHTS ISSUE OF SHARES WITH WARRANTS;(II)        PROPOSED SHARE ISSUANCE SCHEME;(III)        PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL; AND(IV)        PROPOSED AMENDMENT
On behalf of the Board of Directors of Sunzen (“Board”), TA Securities Holdings Berhad (“TA Securities”) wishes to announce that the Company proposes to undertake the following: (i)   proposed renounceable rights issue of up to 192,579,515 new ordinary shares of RM0.10 each in Sunzen (“Sunzen Shares”) (“Rights Shares”) on the basis of three (3) Rights Shares for every five (5) existing Sunzen Shares held, together with up to 192,579,515 free detachable warrants (“Warrants”) on the basis of one (1) Warrant for every one (1) Rights Share subscribed at an entitlement date to be determined later (“Proposed Rights Issue of Shares with Warrants”); (ii)  proposed establishment of a share issuance scheme (“SIS”) of up to thirty percent (30%) of the Company’s issued and paid-up share capital (excluding treasury shares) at any one time during the duration of the SIS for the eligible Directors and employees of Sunzen and its subsidiaries (excluding dormant subsidiaries) (“Proposed SIS”); (iii) proposed increase in authorised share capital of Sunzen from RM50,000,000 comprising 500,000,000 Sunzen Shares to RM100,000,000 comprising 1,000,000,000 Sunzen Shares (“Proposed Increase in Authorised Share Capital”); and (iv) proposed amendment to the Memorandum of Association of Sunzen to facilitate the Proposed Increase in Authorised Share Capital (“Proposed Amendment”) (Collectively referred to as the “Proposals”). Please refer to the attachment for further details of the announcement. This announcement is dated 26 August 2015.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/4846521

Attachments Sunzen - Proposals (26.08.15) final.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2015

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2015	30 Jun 2014	30 Jun 2015	30 Jun 2014
		$$'000	$$'000	$$'000	$$'000

1	Revenue	9,071	9,886	17,107	18,321
2	Profit/(loss) before tax	195	317	618	698
3	Profit/(loss) for the period	178	283	571	544
4	Profit/(loss) attributable to ordinary equity holders of the parent	178	283	571	544
5	Basic earnings/(loss) per share (Subunit)	0.07	0.12	0.22	0.22
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1900		0.0300

APULA

擴大海外市場‧宏誠推新棕油營養品
2015-11-24 17:02
http://biz.sinchew.com.my/node/126667?tid=6

（吉隆坡24日）動物保健品生產商——宏誠生物科技（SUNZEN，0148，創業板消費品組）近期將推出新棕油營養品，進一步擴大其海外市場。

今日股東特大結束後，該公司執行董事兼首席執行員馮俊豪表示，公司目前專注於研發和改良以棕油為原料的動物飼料添加劑。

“我們不能只單靠國內市場，東南亞市場對公司也十分重要。最近，我們也把產品銷售至加拿大以及紐西蘭等國家。”

他也補充，雖然最近棕油價下跌，但公司棕油原料為主的產品才推出市場幾個月，暫時還看不到利多。

他表示，公司目前主要產品是動物保健品，主要是針對豬的飼養方面。公司在國內豬隻飼料添加劑的市佔率約有30至40%左右。

根據該公司手冊介紹，目前公司推出的主打產品是名為“Tomo Fat”的棕櫚脂肪粉，專提供給反芻動物和家禽類食用。

詢及令吉的疲弱是否對公司產生衝擊，他回應，馬幣走跌對公司營運有很大影響，因為他們吸納匯率變化產生的額外成本，並沒有轉嫁給客戶。（星洲日報／財經）

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2015

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Sep 2015	30 Sep 2014	30 Sep 2015	30 Sep 2014
		$$'000	$$'000	$$'000	$$'000

1	Revenue	6,192	8,461	23,299	26,782
2	Profit/(loss) before tax	-410	85	208	783
3	Profit/(loss) for the period	-468	8	103	552
4	Profit/(loss) attributable to ordinary equity holders of the parent	-467	8	104	552
5	Basic earnings/(loss) per share (Subunit)	-0.17	0.00	0.04	0.23
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1800		0.3000

icy97

Type	Announcement
Subject	MULTIPLE PROPOSALS
Description	SUNZEN BIOTECH BERHAD ("SUNZEN" OR THE "COMPANY")(I)        RIGHTS ISSUE OF SHARES WITH WARRANTS; (II)        SHARE ISSUANCE SCHEME;(III)        INCREASE IN AUTHORISED SHARE CAPITAL; AND(IV)        AMENDMENT(COLLECTIVELY REFERRED TO AS THE "CORPORATE EXERCISES")
We refer to the announcements made on 26 August 2015, 4 September 2015, 21 October 2015, 29 October 2015, 30 October 2015 and 24 November 2015 in relation to the Corporate Exercises (“Announcements”). Unless otherwise defined, the definitions set out in the Announcements shall apply herein. On behalf of the Board, TA Securities wishes to announce that Sunzen had on today executed the following: (i) a deed poll constituting the Warrants; and (ii) an underwriting agreement with TA Securities and Mercury Securities Sdn Bhd (collectively referred to as the “Joint Underwriters”), whereby the Joint Underwriters will severally but not jointly underwrite 55,000,000 Rights Shares (representing approximately 49.99% of the total Rights Shares under the Minimum Scenario), subject to the terms and conditions of the underwriting agreement. This announcement is dated 18 January 2016.

icy97

EX-date	29 Jan 2016
Entitlement date	03 Feb 2016
Entitlement time	05:00 PM
Entitlement subject	Rights Issue
Entitlement description	RENOUNCEABLE RIGHTS ISSUE OF UP TO 192,579,515 NEW ORDINARY SHARES OF RM0.10 EACH IN SUNZEN BIOTECH BERHAD ("SUNZEN SHARES") ("RIGHTS SHARES") ON THE BASIS OF THREE (3) RIGHTS SHARES FOR EVERY FIVE (5) EXISTING SUNZEN SHARES HELD AS AT 5.00 P.M. ON 3 FEBRUARY 2016 ("ENTITLEMENT DATE") AT AN ISSUE PRICE OF RM0.25 PER RIGHTS SHARE, TOGETHER WITH UP TO 192,579,515 FREE DETACHABLE WARRANTS ("WARRANTS") ON THE BASIS OF ONE (1) WARRANT FOR EVERY ONE (1) RIGHTS SHARE SUBSCRIBED FOR ("RIGHTS ISSUE OF SHARES WITH WARRANTS")
Period of interest payment	to
Financial Year End
Share transfer book & register of members will be	to   closed from (both dates inclusive) for the purpose of determining the entitlement
Registrar or Service Provider name, address, telephone no	Symphony Share Registrars Sdn BhdLevel 6, Symphony HousePusat Dagangan Dana 1Jalan PJU 1A/4647301 Petaling JayaSelangor Darul EhsanMalaysiaTel. no.: 03-7849 0777  Fax no.: 03-7841 8151/8152
Payment date
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	03 Feb 2016
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)	192,579,515
Entitlement indicator	Ratio
Ratio	3 : 5
Rights Issue/Offer Price	Malaysian Ringgit (MYR) 0.250
Par Value	Malaysian Ringgit (MYR) 0.100

Despatch date	05 Feb 2016
Date for commencement of trading of rights	04 Feb 2016
Date for cessation of trading of rights	15 Feb 2016
Date for announcement of final subscription result and basis of allotment of excess Rights Securities	24 Feb 2016
Listing Date of the Rights Securities	04 Mar 2016

Last date and time for	Date	Time
Sale of provisional allotment of rights	12 Feb 2016	at	05:00:00 PM
Transfer of provisional allotment of rights	17 Feb 2016	at	04:00:00 PM
Acceptance and payment	22 Feb 2016	at	05:00:00 PM
Excess share application and payment	22 Feb 2016	at	05:00:00 PM

icy97

EX-date	29 Jan 2016
Entitlement date	03 Feb 2016
Entitlement time	05:00 PM
Entitlement subject	Adjustment
Entitlement description	ADJUSTMENTS TO THE NUMBER OF THE OUTSTANDING WARRANTS 2014/2019 IN SUNZEN BIOTECH BERHAD ("SUNZEN" OR THE "COMPANY") CONSTITUTED BY THE DEED POLL DATED 28 MARCH 2014 ("DEED POLL") ("WARRANTS 2014/2019") PURSUANT TO THE RENOUNCEABLE RIGHTS ISSUE OF UP TO 192,579,515 NEW ORDINARY SHARES OF RM0.10 EACH IN SUNZEN ("SUNZEN SHARES") ("RIGHTS SHARES") ON THE BASIS OF THREE (3) RIGHTS SHARES FOR EVERY FIVE (5) EXISTING SUNZEN SHARES HELD AS AT 5.00 P.M. ON 3 FEBRUARY 2016 ("ENTITLEMENT DATE") AT AN ISSUE PRICE OF RM0.25 PER RIGHTS SHARE, TOGETHER WITH UP TO 192,579,515 FREE DETACHABLE WARRANTS ("WARRANTS") ON THE BASIS OF ONE (1) WARRANT FOR EVERY ONE (1) RIGHTS SHARE SUBSCRIBED FOR ("RIGHTS ISSUE OF SHARES WITH WARRANTS") ("ADJUSTMENT")
Period of interest payment	to
Financial Year End
Share transfer book & register of members will be	to   closed from (both dates inclusive) for the purpose of determining the entitlement
Registrar or Service Provider name, address, telephone no	SYMPHONY SHARE REGISTRARS SDN BHDLevel 6, Symphony HousePusat Dagangan Dana 1Jalan PJU 1A/4647301 Petaling JayaTel:03-78490777Fax:03-78418151/8152
Payment date
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers	03 Feb 2016
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Ratio
Ratio	16 : 100
Rights Issue/Offer Price
Par Value	Malaysian Ringgit (MYR)

Remarks :

Following the Rights Issue of Shares with Warrants, up to 3,733,750 additional new Warrants 2014/2019 arising from the Adjustment ("Adjustment Warrants") will be allotted and issued on the basis of 16.83 Adjustment Warrants (indicative) for every 100 Warrants 2014/2019 held by the entitled holders of Warrants 2014/2019 of the Company, whose names appear in the Record of Depositors at 5.00 p.m. on the Entitlement Date. Any adjustments to the number of Warrants 2014/2019 will be rounded down to the nearest whole Warrant 2014/2019. However, no adjustment will be made to the existing exercise price of the Warrants 2014/2019 of RM0.10 each as the exercise price of the outstanding Warrants 2014/2019 cannot be adjusted below the par value of the Sunzen Shares of RM0.10 each.The exact adjustment in the exercise price and the number of Warrants 2014/2019 to be issued can only be finalised after the closing date for the application and acceptances for the Rights Shares with Warrants based on the subscription rate of the Rights Shares.The Adjustment Warrants will be listed and quoted simultaneously with the Rights Shares on the ACE Market of Bursa Securities on 4 March 2016. The notice to the holders of Warrants 2014/2019 setting out the details of the Adjustment and the Adjustment Warrants to be issued pursuant to the Rights Issue of Shares with Warrants as well as the notice of allotment of the Adjustment Warrants will be despatched in due course.Holders of Warrants 2014/2019 who wish to be entitled to the Rights Issue of Shares with Warrants should exercise their Warrants 2014/2019 by lodging their duly completed exercise forms together with the subscription monies with Sunzen's share registrar on or before 5.00 p.m. on 26 January 2016 for their names to appear on the Record of Depositors at 5.00 p.m. on the Entitlement Date.This announcement is dated 18 January 2016.

---

Announcement Info

Company Name	SUNZEN BIOTECH BERHAD
Stock Name	SUNZEN-WA
Date Announced	18 Jan 2016
Category	Entitlement(Notice of Book Closure)
Reference Number	ENT-18012016-00005

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	SUNZEN BIOTECH BERHAD (Sunzen or the Company)- Disposal of Property by Sunzen Corporation Sdn. Bhd., a wholly-owned subsidiary of the Company
The Board of Directors of Sunzen is pleased to announce that Sunzen Corporation Sdn. Bhd. (“SCSB” or “Vendor”), a wholly-subsidiary of the Company has on 22 January 2016 entered into a Sale and Purchase Agreement (“SPA”) with Mr Ang Kian Bing (NRIC No. 680520-06-5193) (“Purchaser”) for the disposal of a one and half storey corner semi-detached factory measuring approximately 1,471 square meters and held under the individual title HS(D) 55014, PT No. 56433 in the Mukim of Klang, District Klang, State of Selangor Darul Ehsan (“Property”), for a total cash consideration of RM3,301,887.00 which is exclusive of goods and services tax (“GST”) of 6% (“Sale Consideration”) (“Disposal of Property”). The full texts of the annoucement is attached.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/4984273

Attachments Attachment - Disposal of Property.pdf

icy97

Type	Announcement
Subject	NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) FUND RAISING
Description	SUNZEN BIOTECH BERHAD ("SUNZEN" OR THE "COMPANY")RENOUNCEABLE RIGHTS ISSUE OF UP TO 192,579,515 NEW ORDINARY SHARES OF RM0.10 EACH IN SUNZEN ("SUNZEN SHARES") ("RIGHTS SHARES") ON THE BASIS OF THREE (3) RIGHTS SHARES FOR EVERY FIVE (5) EXISTING SUNZEN SHARES HELD AS AT 5.00 P.M. ON 3 FEBRUARY 2016 AT AN ISSUE PRICE OF RM0.25 PER RIGHTS SHARE, TOGETHER WITH UP TO 192,579,515 FREE DETACHABLE WARRANTS ("WARRANTS") ON THE BASIS OF ONE (1) WARRANT FOR EVERY ONE (1) RIGHTS SHARE SUBSCRIBED FOR
We refer to the announcements made on 26 August 2015, 4 September 2015, 21 October 2015, 29 October 2015, 30 October 2015, 24 November 2015, 18 January 2016, 22 January 2016, 2 February 2016 and 3 February 2016 in relation to, amongst others, the Rights Issue of Shares with Warrants (“Announcements”). Unless otherwise defined, the definitions set out in the Announcements shall apply herein. On behalf of the Board, TA Securities wishes to announce that as at the close of acceptance, excess application and payment for the Rights Issue of Shares with Warrants at 5.00 p.m. on 22 February 2016 (“Closing Date”), the total valid acceptances and excess applications received for the Rights Issue of Shares with Warrants was 204,651,410 Rights Shares with Warrants, representing approximately 114.06% of the Rights Shares with Warrants available for acceptances under the Rights Issue of Shares with Warrants, which represents an over-subscription rate of 14.06%. The details of valid acceptances and excess applications received as at the Closing Date are as follows: No. of Rights Shares with Warrants Percentage of total Rights Shares with Warrants available for acceptance (%) Total valid acceptances 173,451,242 96.67 Total valid excess applications 31,200,168 17.39 Total valid acceptances and excess applications 204,651,410 114.06 Total Rights Shares with Warrants available for subscription 179,423,296 100.00 Over-subscription 25,228,114 14.06 The Board has applied the following basis in allocating the excess Rights Shares with Warrants, in accordance with the Abridged Prospectus dated 3 February 2016: (i) firstly, to minimise the incidence of odd lots; (ii) secondly, on a pro-rata basis and in board lots, to the Entitled Shareholders who have applied for the excess Rights Shares with Warrants, based on their respective shareholdings in the Company as at the Entitlement Date; (iii) thirdly, on a pro-rata basis and in board lots, to the Entitled Shareholders who have applied for excess Rights Shares with Warrants, based on the quantum of their respective excess application; and (iv) lastly, on a pro-rata basis and in board lots, to the transferees and/or renouncees who have applied for excess Rights Shares with Warrants, based on the quantum of their respective excess application. The Rights Shares with Warrants are expected to be listed and quoted on the ACE Market of Bursa Securities on 4 March 2016. This announcement is dated 24 February 2016.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Dec 2015

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Dec 2015	31 Dec 2014	31 Dec 2015	31 Dec 2014
		$$'000	$$'000	$$'000	$$'000

1	Revenue	8,922	10,557	32,221	37,339
2	Profit/(loss) before tax	-467	608	-259	1,391
3	Profit/(loss) for the period	-450	548	-347	1,100
4	Profit/(loss) attributable to ordinary equity holders of the parent	-452	548	-348	1,100
5	Basic earnings/(loss) per share (Subunit)	-0.16	0.22	-0.12	0.44
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1800		0.3000

icy97

SUNZEN BIOTECH BERHAD

1. Details of Corporate Proposal
Involve issuance of new type/class of securities ?	No
Types of corporate proposal	Rights Issue
Details of corporate proposal	Additional Warrants 2014/2019 issued pursuant to the Rights Issue of Shares with Warrants ("Adjustment Warrants")
No. of shares issued under this corporate proposal	3,605,952
Issue price per share ($$)	Malaysian Ringgit (MYR)   0.0000
Par Value ($$)	Malaysian Ringgit (MYR)   0.000
Latest issued and paid up share capital after the above corporate proposal in the following
Units	25,034,966
Currency	Malaysian Ringgit (MYR) 0.000
Listing Date	04 Mar 2016

icy97

Profile for Securities of PLC

Amended Announcements
Please refer to the earlier announcement reference number: LIP-05052015-00005

SUNZEN BIOTECH BERHAD

Instrument Category	Securities of PLC
Instrument Type	Warrants
Description	Adjustment to the number of outstanding warrants 2014/2019 in Sunzen Biotech Berhad ("Sunzen") ("Warrants 2014/2019") pursuant to the renounceable rights issue of 179,423,296 new ordinary shares of RM0.10 each in Sunzen ("Sunzen Shares") ("Rights Shares") on the basis of three (3) Rights Shares for every five (5) existing Sunzen Shares held as at 5.00 p.m. on 3 February 2016 at an issue price of RM0.25 per Rights Share, together with 179,423,296 free detachable warrants ("Warrants") on the basis of one (1) Warrant for every one (1) Rights Share subscribed for ("Rights Issue of Shares with Warrants") ("Adjustment")

1st Further Issue Information

Listing Date	06 May 2015
Issue Date	05 May 2015
Issue/ Ask Price	Not Applicable
Issue Size Indicator	Unit
Amount Issued under Further Issue in Unit	11,729,986
Enlarge Issue Size in Unit	61,486,246

2nd Further Issue Information

Listing Date	04 Mar 2016
Issue Date	26 Feb 2016
Issue/ Ask Price	Not Applicable
Issue Size Indicator	Unit
Amount Issued under Further Issue in Unit	3,605,952
Enlarge Issue Size in Unit	65,092,198

Initial Listing Information

Listing Date	21 Apr 2014
Issue Date	15 Apr 2014
Issue/ Ask Price	Not Applicable
Issue Size Indicator	Unit
Issue Size in Unit	49,756,260
Maturity	Mandatory
Maturity Date	14 Apr 2019
Revised Maturity Date
Name of Guarantor	Not Applicable
Name of Trustee	Not Applicable
Coupon/Profit/Interest/Payment Rate	Not Applicable
Coupon/Profit/Interest/Payment Frequency	Not Applicable
Redemption	Not Applicable
Exercise/Conversion Period	5.00   Year(s)
Revised Exercise/Conversion Period	Not Applicable
Exercise/Strike/Conversion Price	Malaysian Ringgit (MYR)   0.1000
Revised Exercise/Strike/Conversion Price	Not Applicable
Exercise/Conversion Ratio	1:1
Revised Exercise/Conversion Ratio	Not Applicable
Mode of satisfaction of Exercise/ Conversion price	Cash
Settlement Type/ Convertible into	Physical (Shares)

Remarks :

Pursuant to the Rights Issue of Shares with Warrants, an additional 3,605,952 Warrants 2014/2019 will be listed and quoted on the ACE Market of Bursa Securities on 4 March 2016.The notice to the holders of the Warrants 2014/2019 containing details of the Adjustments was despatched to the holders of the Warrants 2014/2019 on 29 February 2016.This announcement is dated 3 March 2016.

---

Announcement Info

Company Name	SUNZEN BIOTECH BERHAD
Stock Name	SUNZEN-WA
Date Announced	03 Mar 2016
Category	Listing Information and Profile
Reference Number	LIP-03032016-00001

icy97

Instrument Category	Securities of PLC
Instrument Type	Warrants
Description	Issuance of 179,423,296 free detachable warrants ("Warrants") to the entitled shareholders of Sunzen Biotech Berhad ("Sunzen") pursuant to the renounceable rights issue of 179,423,296 new ordinary shares of RM0.10 each in Sunzen ("Sunzen Shares") ("Rights Shares") on the basis of three (3) Rights Shares for every five (5) existing Sunzen Shares held as at 5.00 p.m. on 3 February 2016 at an issue price of RM0.25 per Rights Share, together with 179,423,296 free detachable warrants ("Warrants") on the basis of one (1) Warrant for every one (1) Rights Share subscribed for ("Rights Issue of Shares with Warrants")

Listing Date	04 Mar 2016
Issue Date	26 Feb 2016
Issue/ Ask Price	Not Applicable
Issue Size Indicator	Unit
Issue Size in Unit	179,423,296
Maturity	Mandatory
Maturity Date	25 Feb 2021
Revised Maturity Date
Name of Guarantor	Not Applicable
Name of Trustee	Not Applicable
Coupon/Profit/Interest/Payment Rate	Not Applicable
Coupon/Profit/Interest/Payment Frequency	Not Applicable
Redemption	Not Applicable
Exercise/Conversion Period	5.00   Year(s)
Revised Exercise/Conversion Period	Not Applicable
Exercise/Strike/Conversion Price	Malaysian Ringgit (MYR)   0.2500
Revised Exercise/Strike/Conversion Price	Not Applicable
Exercise/Conversion Ratio	1:1
Revised Exercise/Conversion Ratio	Not Applicable
Mode of satisfaction of Exercise/ Conversion price	Cash
Settlement Type/ Convertible into	Physical (Shares)

Remarks :

Each Warrant carries the entitlement to subscribe for one (1) new Sunzen Share at the exercise price (as indicated above) and at any time during the exercise period (as indicated above) ("Exercise Period") subject to the adjustments in accordance with the provisions of the deed poll dated 18 January 2016, constituting the Warrants. Any Warrants not exercised during the Exercise Period will thereafter lapse and cease to be valid for any purpose.This announcement is dated 3 March 2016.

---

Announcement Info

Company Name	SUNZEN BIOTECH BERHAD
Stock Name	SUNZEN-WB
Date Announced	03 Mar 2016
Category	Listing Information and Profile

APULA

宏誠生科籌獲4485萬 附加股超購14%
2016年3月06日
http://www.chinapress.com.my/20160306/宏誠生科籌獲4485萬-附加股超購14/

（莎阿南6日訊）宏誠生科（SUNZEN，0148，創業板消費）發行的可棄權附加股獲超額認購14.06%，成功籌措近4485萬5824令吉資金用作拓展計劃。

該公司發佈文告指出，上述附加股計劃是在2月22日截止，原定發售的1億7942萬3296附加股，收到總數2522萬8114股的超額認購，相等于超購14.06%。

上述附加股及憑單已在上週五于馬股上市交易。

宏誠生科總執行長馮俊豪說：“董事局非常感謝重要股東們給予大力支持，這份支持已通過附加股認購總額加以驗證。這也充分展現出股東對公司未來在相關領域的發展深具信心。”

他說，公司將持續成為研發、生產及經銷安全優質動物保健產品的領銜公司，並透露將在第3季推出新產品。

宏誠生科計劃注資600萬令吉裝置新機器，包括雙重製油機以提高棕油硬脂的產量；撥款130萬令吉提升現有工廠兼辦公室設備，以增設全新展示廳及研究開發實驗室。

該公司也另外撥出295萬6000令吉強化在我國、中國、越南和伊朗市場的市場行銷及宣傳活動。目前，該公司也與伊朗及韓國當地經銷商商討相關拓展計劃。

icy97

Name	MR HONG CHOON HAU
Address	10, JALAN MARGOSA SD10/4C BANDAR SRI DAMANSARA KUALA LUMPUR 52200 Wilayah Persekutuan Malaysia.
NRIC/Passport No/Company No.	761113025869
Nationality/Country of incorporation	Malaysia
Descriptions (Class & nominal value)	ORDINARY SHARES OF RM0.10 EACH
Name & address of registered holder	MAYBANK SECURITIES NOMINEES (TEMPATAN) SDN. BHD.MAYBANK KIM ENG SECURITIES PTE LTD FOR MAYBANK PTE LTD (A/C 649063)LEVEL 5 MAYBANLIFE TOWERDATARAN MAYBAN1 JALAN MAAROF59000 KUALA LUMPUR

Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transaction	Description of Others	Date of change	No of securities	Price Transacted (RM)
Others	RIGHTS ISSUE	03 Mar 2016	51,741,400

Circumstances by reason of which change has occurred	RIGHTS ISSUE
Nature of interest	DIRECT
Direct (units)	131,310,400
Direct (%)	27.444
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Total no of securities after change	131,310,400
Date of notice	07 Mar 2016

icy97

股價挫近半 宏誠生科陷超賣
  
2016年3月10日
（吉隆坡10日訊）技術分析顯示，宏誠生科（SUNZEN，0148，創業板消費股）慘遭超賣，股價由46仙的52週高點慘摔47.8%至24仙。

宏誠生科今日以揚0.5仙至28仙報開；休市平盤暫掛27.5仙，半日成交582萬1100股。閉市時，該股報27仙，跌0.5仙，成交量658萬6500股。

豐隆投銀研究稱，宏誠生科慘遭超賣，導致于去年6月24日創下52週新高的股價在3月4日重挫47.8%至24仙。

不過，據技術分析圖顯示，該股已浮現平頭底部形態（Tweezers Bottom）和孕婦形態（Bullish Harami）。因此，該研究預計，宏誠生科將在近期內恢復揚勢。

同時，豐隆投銀研究瞄准該公司股價的即時阻力水平在介于29.5仙至32仙之間，高于32仙的決定性突破點將推動股價攀高至該研究的長期目標，即35仙。

“支撐點落在26仙（10小時移動平均線）和25仙（3月7日至9日低點），止損點則在24.5仙。”【中国报财经】

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2016

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2016	31 Mar 2015	31 Mar 2016	31 Mar 2015
		$$'000	$$'000	$$'000	$$'000

1	Revenue	8,059	8,036	8,059	8,036
2	Profit/(loss) before tax	-1,210	423	-1,210	423
3	Profit/(loss) for the period	-1,214	393	-1,214	393
4	Profit/(loss) attributable to ordinary equity holders of the parent	-1,227	393	-1,227	393
5	Basic earnings/(loss) per share (Subunit)	-0.40	0.16	-0.40	0.16
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2000		0.1800

icy97

SUNZEN BIOTECH BERHAD

Particulars of substantial Securities Holder

Name	MR HONG CHOON HAU
Nationality/Country of incorporation	Malaysia
Descriptions (Class & nominal value)	ORDINARY SHARES OF RM0.10 EACH
Name & address of registered holder	HONG CHOON HAU10, JALAN MARGOSA SD10/4CBANDAR SRI DAMANSARA52200 KUALA LUMPUR

Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transaction	Description of Others	Date of change	No of securities	Price Transacted (RM)
Acquired		15 Jun 2016	8,931,600

Circumstances by reason of which change has occurred	ACQUISITION VIA OFF MARKET
Nature of interest	DIRECT
Direct (units)	140,242,000
Direct (%)	29.301
Indirect/deemed interest (units)
Indirect/deemed interest (%)
Total no of securities after change	140,242,000
Date of notice	16 Jun 2016

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2016

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2016	30 Jun 2015	30 Jun 2016	30 Jun 2015
		$$'000	$$'000	$$'000	$$'000

1	Revenue	10,008	9,071	18,067	17,107
2	Profit/(loss) before tax	-305	195	-1,515	618
3	Profit/(loss) for the period	-309	178	-1,523	571
4	Profit/(loss) attributable to ordinary equity holders of the parent	-361	178	-1,588	571
5	Basic earnings/(loss) per share (Subunit)	-0.10	0.07	-0.45	0.22
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)

icy97

Type	Announcement
Subject	MEMORANDUM OF UNDERSTANDING
Description	SUNZEN BIOTECH BERHAD ("SUNZEN")- STATUS UPDATE ON THE MEMORANDUM OF UNDERSTANDING ("MOU") BETWEEN UNIVERSITI PUTRA MALAYSIA AND SUNZEN
Further to the Company's announcement made on 26 May 2016, the Board of Directors of Sunzen wishes to announce that the MOU has lapsed. This announcement is dated 25 August 2016.

Type	Announcement
Subject	MEMORANDUM OF UNDERSTANDING
Description	SUNZEN BIOTECH BERHAD ("SUNZEN")- STATUS UPDATE ON THE MEMORANDUM OF UNDERSTANDING ("MOU") BETWEEN SUNZEN FEEDTECH SDN. BHD. AND UNIVERSITI SAINS MALAYSIA
Further to the Company's announcement made on 26 May 2016, the Board of Directors of Sunzen wishes to announce that the MOU has lapsed. This announcement is dated 25 August 2016.